Development of daptomycin for gram-positive infections.
Tally
F P
FP
Cubist Pharmaceuticals, Inc., 24 Emily Street, Cambridge, MA 02139, USA. ftally@cubist.com
DeBruin
M F
MF
D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D017576:Daptomycin / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans
D000900:Anti-Bacterial Agents; D017576:Daptomycin